According to Genetic Technologies's latest financial reports and stock price the company's current number of shares outstanding is 129,424. At the end of 2008 the company had 129,424 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2008 | 0.12 M | 0% |
2007 | 0.12 M | 0% |
2006 | 0.12 M | -0% |
2005 | 0.12 M | 21.74% |
2004 | 0.1 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 298,917.18% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 112,000,000 | 86,437.27% | ๐บ๐ธ USA |
Danaher DHR | 739,800,000 | 571,509.59% | ๐บ๐ธ USA |
LabCorp LH | 84,900,000 | 65,498.34% | ๐บ๐ธ USA |
Compugen CGEN | 88,310,329 | 68,133.35% | ๐ฎ๐ฑ Israel |
Neogen NEOG | 216,597,777 | 167,255.19% | ๐บ๐ธ USA |
Myriad Genetics MYGN | 81,900,000 | 63,180.38% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 5,410,000 | 4,080.06% | ๐บ๐ธ USA |